Robert B Clarke

Robert B Clarke

Manchester University

H-index: 66

North America-United States

About Robert B Clarke

Robert B Clarke, With an exceptional h-index of 66 and a recent h-index of 39 (since 2020), a distinguished researcher at Manchester University, specializes in the field of breast cancer, stem cells, endocrine resistance, Notch signalling, patient-derived xenografts.

His recent articles reflect a diverse array of research interests and contributions to the field:

Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer

International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology …

Proteomics of Patient-derived Breast Tumours Identifies a Pro-migratory Osteomodulin-Cyclin Dependent Kinase 1 Axis which Drives Bone Metastasis

Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research

Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy

RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

Prevention Of Breast and Endometrial cancer using Total Diet Replacement (PROBE-TDR) trial: protocol for a randomised controlled trial

Robert B Clarke Information

University

Position

Professor of Breast Biology

Citations(all)

17025

Citations(since 2020)

6174

Cited By

13453

hIndex(all)

66

hIndex(since 2020)

39

i10Index(all)

126

i10Index(since 2020)

91

Email

University Profile Page

Manchester University

Google Scholar

View Google Scholar Profile

Robert B Clarke Skills & Research Interests

breast cancer

stem cells

endocrine resistance

Notch signalling

patient-derived xenografts

Top articles of Robert B Clarke

Title

Journal

Author(s)

Publication Date

Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer

Proceedings of the National Academy of Sciences

Shi-Yang Li

Jan A Hammarlund

Gang Wu

Jia-Wen Lian

Sacha J Howell

...

2024/2/13

International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology …

Icro Meattini

Carlotta Becherini

Saverio Caini

Charlotte E Coles

Javier Cortes

...

2024/2/1

Proteomics of Patient-derived Breast Tumours Identifies a Pro-migratory Osteomodulin-Cyclin Dependent Kinase 1 Axis which Drives Bone Metastasis

bioRxiv

Joseph Parsons

Hannah Harrison

Tom Kedward

Paul Fullwood

Sara Cabral

...

2023

Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research

Renée van Amerongen

Mohamed Bentires-Alj

Antonius L van Boxtel

Robert B Clarke

Silvia Fre

...

2023/12

Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy

Veronica Vella

Rosamaria Lappano

Eduardo Bonavita

Marcello Maggiolini

Robert Bryan Clarke

...

2023/8

RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells

Oncogene

Fuhui Chen

Sevim B Gurler

David Novo

Cigdem Selli

Denis G Alferez

...

2023/2/24

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

Nature communications

Marta Palafox

Laia Monserrat

Meritxell Bellet

Guillermo Villacampa

Abel Gonzalez-Perez

...

2022/9/7

Prevention Of Breast and Endometrial cancer using Total Diet Replacement (PROBE-TDR) trial: protocol for a randomised controlled trial

BMJ Open

Helen Clarke

Michelle Harvie

Cheryl Lombardelli

Suzanne Krizak

Katharine Sellers

...

2022/7/1

Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women

Genome medicine

Thomas E Bartlett

Iona Evans

Allison Jones

James E Barrett

Shaun Haran

...

2022/6/15

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

Cancer research

Benedetta Pellegrino

Andrea Herencia-Ropero

Alba Llop-Guevara

Flaminia Pedretti

Alejandro Moles-Fernández

...

2022/4/15

Reciprocal priming between receptor tyrosine kinases at recycling endosomes orchestrates cellular signalling outputs

The EMBO Journal

Michael P Smith

Harriet R Ferguson

Jennifer Ferguson

Egor Zindy

Katarzyna M Kowalczyk

...

2021/7/15

FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity

NPJ Breast Cancer

Simon Timbrell

Hosam Aglan

Angela Cramer

Phil Foden

David Weaver

...

2021/5/28

Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors

Nature Communications

Karsten Bach

Sara Pensa

Marija Zarocsinceva

Katarzyna Kania

Julie Stockis

...

2021/3/9

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

Nature genetics

Xing Yi Woo

Jessica Giordano

Anuj Srivastava

Zi-Ming Zhao

Michael W Lloyd

...

2021/1

Increased expression of interleukin-1 receptor characterizes anti-estrogen-resistant ALDH+ breast cancer stem cells

Stem Cell Reports

Aida Sarmiento-Castro

Eva Caamaño-Gutiérrez

Andrew H Sims

Nathan J Hull

Mark I James

...

2020/8/11

Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer

Oncogene

Bruno M Simões

Angélica Santiago-Gómez

Chiara Chiodo

Tiago Moreira

Daniel Conole

...

2020/6/18

Tailored functionalized magnetic nanoparticles to target breast cancer cells including cancer stem-like cells

Cancers

Ana Lazaro-Carrillo

Macarena Calero

Antonio Aires

Aitziber L. Cortajarena

Bruno M Simões

...

2020/5/29

Preparation of a user-defined peptide gel for controlled 3D culture models of cancer and disease

JoVE (Journal of Visualized Experiments)

Jennifer C Ashworth

Rebecca L Morgan

Kataryna Lis-Slimak

Kate A Meade

Sal Jones

...

2020/12/3

See List of Professors in Robert B Clarke University(Manchester University)

Co-Authors

H-index: 152
Anthony Howell, Howell A, Howell T

Anthony Howell, Howell A, Howell T

Manchester University

H-index: 105
Manuel Hidalgo

Manuel Hidalgo

Cornell University

H-index: 68
Charles Streuli

Charles Streuli

Manchester University

H-index: 40
Martin Baron

Martin Baron

Manchester University

H-index: 40
Michelle Harvie

Michelle Harvie

Manchester University

H-index: 33
Ernestina Marianna De Francesco

Ernestina Marianna De Francesco

Manchester University

academic-engine